Limbal Stem-cell Deficiency Clinical Trial
Official title:
Cultivated Limbal Epithelial Transplantation (CLET) for Limbal Stem Cell Deficiency (LSCD): an Observational Study on Safety and Effectiveness
CLET is a published treatment for the management of corneal failure due to extensive LSCD. Due to our previous studies on this novel treatment, the regulatory agency of Spain "Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)" authorized our institution (IOBA-University of Valladolid) to perform this kind of therapy (CLET) in a case-by-case base following the Special Situation Medicines Policy Procedure in Spain. Upon approval of the permanent authorization patients will be included as specified by AEMPS.The objective of this study is to perform a protocolized treatment and follow up so that results can be reported to the scientific community.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03957954 -
Stem Cell Therapy for Limbal Stem Cell Deficiency
|
Phase 1 | |
Recruiting |
NCT05909735 -
Treatment of LSCD With DM
|
Phase 1 | |
Completed |
NCT03594370 -
Multiple Noninvasive Examination Modality to Evaluate the Severity of Ocular Surface Disorders
|
||
Recruiting |
NCT04021134 -
The Effects of Allogeneic SLET
|
||
Recruiting |
NCT04021875 -
The Effects of Autologous SLET
|
||
Completed |
NCT03226015 -
Autologous Oral Mucosa Transplantation for Limbal Stem Cell Deficiency
|
N/A | |
Recruiting |
NCT04995926 -
Labial Mucosal Epithelium Grafting for Corneal Limbus Substitution
|
N/A | |
Completed |
NCT05461469 -
CDL Validation Study
|
||
Completed |
NCT02415218 -
Transplantation of Autologous Oral Mucosal Epithelial Sheets for Limbal Stem-cell Deficiency
|
Phase 1/Phase 2 |